Simple wash during surgery may stop rectal cancer return
NCT ID NCT07512232
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether rinsing the rectal cavity with a saltwater or iodine solution during laparoscopic surgery can prevent local recurrence of mid-to-low rectal cancer. About 1,600 patients will be randomly assigned to receive the wash or not, and they will be followed for five years. The goal is to see if this simple step reduces the chance of cancer growing back near the surgery site.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- rectal irrigation with normal saline or povidone-iodine
- What this could lead to
- If it works, this simple procedure could become a standard step during rectal cancer surgery to lower the chance of cancer returning.
- What could go wrong
- This is a large trial, but the procedure is new for this purpose and may not reduce recurrence. There is also a small risk of infection or irritation from the wash.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,598 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
May 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 75 years old. * Pathologically confirmed rectal adenocarcinoma. * Mid-to-low rectal cancer with the tumor lower margin located ≤10 cm from the anal verge. * Underwent laparoscopic radical resection for rectal cancer with sphincter preservation. * Without concomitant multiple primary malignancies. * Adequate organ function. * Patients or their family members were able to understand the study protocol, willing to participate in this study, and provided written informed consent. Exclusion Criteria: * Concomitant other malignancies or a history of prior malignancies. * Abdominal perineal resection (Miles' operation) or Hartmann's procedure. * Failure to open the peritoneal reflection during surgery. * History of previous pelvic floor surgery. * Emergency surgery due to bowel obstruction. * Severe hepatic, renal, cardiopulmonary, or coagulation dysfunction, or other severe comorbidities that render the patient unable to tolerate the procedure. * History of severe psychiatric disorders. * Pregnant or lactating women. * Any other clinical or laboratory conditions considered unsuitable for participation in the trial by the investigators.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Middle and low rectal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 518000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immunotherapy added to standard treatment aims to save the anus in Ultra-Low rectal cancer
- New injectable drug tested against Hard-to-Treat solid tumors
- Could a nasal tube replace a temporary ileostomy after rectal cancer surgery?
- Blood test aims to catch Cancer's return earlier
- Blood test guides immunotherapy for hidden cancer cells
- Can Pre-Surgery radiation stop rectal cancer from returning?